Answer
Pomalidomide Zentiva with dexamethasone is indicated for adults with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on their last therapy.
Sources for this answer
- Pomalidomide Zentiva 1mg hard capsZentiva · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked